About Conatus Pharma
Conatus Pharma is a publicly listed company based in San Diego (United States) founded in 2005. It operates as a novel medicines for liver diseases are developed and commercialized. Conatus Pharma has raised $67.38 million across 7 funding rounds from investors including Novartis, Genechem and Turmeric Acquisition Corp. The company has 22 employees. Its chief executive is Steven J Mento. Conatus Pharma offers products and services including Levitra, Doxycycline, Viagra, and Kamagra. Its focus areas include HealthTech, Healthcare Booking Platforms, Pharmacies and Drugs. Its legal entity is HISTOGEN INC. Its competitors include Capsule, Blink Health, NimbleRx, Phil and Scriptdrop and 4 more; 7 of its 9 listed competitors have raised funding.
Company details
Conatus is focused on the development and commercialization of novel medicines to treat liver disease. Lead compound, emricasan, is an orally active pan-caspase protease inhibitor designed to reduce the activity of human caspases, which are enzymes that mediate inflammation and apoptosis. By reducing the activity of these enzymes, emricasan has the potential to interrupt the progression of liver disease and potentially provide treatment options in multiple areas of liver disease. Phase 2 results for emricasan have been published as of now for portal hypertension and liver cirrhosis. Conatus acquired idun subsidiary of pfizer in 2015 to expand its therapeutic reach to oncology
- Headquarters San Diego, United States
- Employees 22
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website conatuspharma.com
- Social LinkedIn
- Legal Name Histogen Inc.
- Annual Revenue$3.77 M (USD)265as on Dec 31, 2022
- Total Equity Funding$67.38M (USD)
in 7 rounds
- Latest Funding Round$50M (USD), Debt – Conventional
Dec 2016
- InvestorsNovartis
& 7 more
- Employee Count22
Products & Services of Conatus Pharma
Conatus Pharma offers a comprehensive portfolio of products and services, including Levitra, Doxycycline, Viagra, and Kamagra.
Medication for treating erectile dysfunction symptoms.
Antibiotic used for bacterial infections and related conditions.
Drug for managing erectile dysfunction effectively.
Sildenafil-based medication for erectile dysfunction relief.
Funding Insights of Conatus Pharma
Conatus Pharma has successfully raised a total of $67.38M across 7 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $50 million completed in December 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $67.38M
- Total Rounds 7
- Last Round Debt – Conventional — $50M
- First Round $6.6M
(Dec 2006)
- Investors Count 8
All 7 funding rounds of Conatus Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2016 | $50M | Debt – Conventional | – | – | |
| Jun 2013 | $1M | Series B | – | – | – |
| Apr 2011 | $7.5M | Series B | – | – | |
| Feb 2011 | $25.28M | Series B | – | Genechem | |
| Oct 2010 | $5M | Series A | – | – | – |
| May 2007 | $22M | Series A | – | – | – |
| Dec 2006 | $6.6M | Series A | – | – | – |
8 investors in total: 8 institutional.
Investors in Conatus Pharma
Conatus Pharma has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Novartis, Genechem and Turmeric Acquisition Corp.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
US Life-Sciences sectors are targeted for investment by Aberdare Ventures. | – | aberdare.com | San Francisco, United States | |
Stage-agnostic investments in US life-sciences sectors are managed. | – | baycitycapital.com | San Francisco, United States | |
Early and mid-stage life science focused VC firm investing in the US and Europe | – | adventls.com | London, United Kingdom | |
Private equity and venture captial firm focused on healthcare sectors | – | gildehealthcare.com | Cambridge, United States | |
Corporate-backed venture capital firm focused on the healthcare sector | – | roche.com/venturefund.htm | - | |
R&D focused on manufacturing of drugs for multiple therapeutic areas | 1996 | novartis.com | Basel, Switzerland | |
Invests in biotech firms developing life-saving drugs and technologies. | – | mpmcapital.com | - | |
Molecular biology products and services are developed by Genechem. | 2002 | genechem.com.cn | Shanghai, China |
Investor details for Conatus Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Conatus Pharma
13 people are tracked at Conatus Pharma (4 in leadership, 7 in board & advisors, 2 in team); the tracked headcount is 22.
| Name | Role | Group |
|---|---|---|
Steven J Mento | CEO | Leadership |
Alfred P. Spada | Executive Vice President, Research and Development, and Chief Scientific Officer | Leadership |
Keith W. Marshall | Executive Vice President, Chief Operating Officer, and Chief Financial Officer | Leadership |
Michelle L. Vandertie | VP, Finance | Leadership |
Harold Van Wart | Board Member | Board & advisors |
David Hale | Chairman | Board & advisors |
Preston S. Klassen | Board Member | Board & advisors |
Daniel L. Kisner | Board Member | Board & advisors |
Louis Lacasse | Board Member | Board & advisors |
Shahzad Malik | Board Member | Board & advisors |
Jim Scopa | Board Member | Board & advisors |
Daniel L. Ripley | SVP, Business Development, Program & Alliance Management | Team |
David T. Hagerty | EVP, Clinical Development | Team |
Complete people profiles for Conatus Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Conatus Pharma
4 dated milestones of Conatus Pharma across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Conatus Pharma is founded.
- Funding First funding round of $6.6M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Debt – Conventional, of $50.0M.
Competitors of Conatus Pharma
Conatus Pharma has 9 listed competitors in our database, 7 of them funded. They include Capsule, Blink Health, NimbleRx, Phil and Scriptdrop, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| capsule.com | 2015 | New York, United States | $570M | 715 | An online pharmacy platform is operated for medicine delivery services. | |
| blinkhealth.com | 2015 | New York, United States | $90M | 278 | Discounted prescription drugs are provided via an online pharmacy platform. | |
| nimblerx.com | 2014 | Palo Alto, United States | $42.87M | 76 | Prescriptions are delivered same-day through an online platform. | |
| phil.us | 2015 | San Francisco, United States | $105.54M | 99 | Prescription drugs refill management solutions | |
| scriptdrop.co | 2016 | Jacksonville, United States | $30.64M | 95 | On-demand prescription delivery is facilitated for patients through pharmacists' workflows. | |
| joincabinet.com | 2018 | New York, United States | – | – | Software is offered for executive assistants' task tracking and scheduling. | |
| pharmapacks.com | 2011 | Hauppauge, United States | $322.5M | 984 | Pharmaceutical, nutritional, and daily use products are offered via e-commerce. | |
| drugstore.com | 1998 | Bellevue, United States | $63M | – | Medical products and prescriptions are sold online by Drugstore.com. | |
| healthwarehouse.com | 2001 | Loveland, United States | – | 92 | Prescription drugs are dispensed online via mail-order by HealthWarehouse.com. |
Detailed competitors of Conatus Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Conatus Pharma
The website of Conatus Pharma (conatuspharma.com) receives about 1K visits a month and ranks #14,248,892 among all websites worldwide, #8,540 in Biotechnology and Pharmaceuticals.
- Monthly visits1K
▼ 0.6% vs previous month
- Global rank#14,248,892
among all websites
- Category rank#8,540
Health · Biotechnology and Pharmaceuticals
- Bounce rate40%
- Pages per visit1.1
- DevicesDesktop 39% · Mobile 61%
Websites whose visitors overlap most with Conatus Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| portola.com | 100% | – | – | View details | |
| luitpold.com | 100% | 1K | #15,337,585 | View details | |
| aeriepharma.com | 100% | – | – | View details | |
merrimackpharma.com | merrimackpharma.com | 99% | – | – | – |
Top companies in Digital Health & Telemedicine
10 companies that operate in the same segment as Conatus Pharma (Digital Health & Telemedicine), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of an online pharmacy with doctor listing and teleconsultation services | 2015 | Delhi, Delhi, India | USD 230.8 M | USD 328.97 M | 5,212 | |
Online platform offering multiple healthcare services | 2013 | Bengaluru, Karnataka, India | USD 199.22 M | USD 62.4 M | 52 | |
An application is provided for comparing prescription drug prices nationwide. | 2011 | Santa Monica, California, United States | USD 22.21 M | USD 796.85 M | 1,063 | |
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
An online marketplace for healthcare products is operated. | 2011 | Kolkata, West Bengal, India | USD 38.26 M | – | – | |
Alto Pharmacy is focused on providing convenient prescription delivery services. | 2015 | San Francisco, California, United States | USD 591.64 M | – | 802 | |
Membership-based primary care platform is offered for employees and consumers. | 2007 | San Francisco, California, United States | USD 402.56 M | – | – | |
Telehealth solutions are provided for doctors and patients' consultations. | 2006 | Boston, Massachusetts, United States | USD 887.35 M | USD 115.54 M | 742 | |
Digital health services for men's wellness are offered by Ro. | 2017 | New York, New York, United States | USD 1.03 B | – | 1,485 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Conatus Pharma
Complete news archive for Conatus Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Conatus Pharma
Conatus Pharma was founded in 2005 and raised its 1st funding round 1 year after it was founded.
Conatus Pharma is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Steven J Mento is the current CEO of Conatus Pharma.
Conatus Pharma is a funded company, having raised a total of $67.38M across 7 funding rounds to date. The company's 1st funding round was a Series A of $6.6M, raised on Dec 2006.
Conatus Pharma has 22 employees.
Annual revenue of Conatus Pharma is $3.77M as on Dec 31, 2022.
Conatus is focused on the development and commercialization of novel medicines to treat liver disease. Lead compound, emricasan, is an orally active pan-caspase protease inhibitor designed to reduce the activity of human caspases, which are enzymes that mediate inflammation and apoptosis. By reducing the activity of these enzymes, emricasan has the potential to interrupt the progression of liver disease and potentially provide treatment options in multiple areas of liver disease. Phase 2 results for emricasan have been published as of now for portal hypertension and liver cirrhosis. Conatus acquired idun subsidiary of pfizer in 2015 to expand its therapeutic reach to oncology.
Conatus Pharma's top competitors include Capsule, Blink Health and Phil.
Conatus Pharma offers Levitra, Doxycycline, Viagra, and Kamagra.
Conatus Pharma has 8 investors. Key investors include Novartis, Genechem, Turmeric Acquisition Corp, Aberdare Ventures, and Bay City Capital.
Conatus Pharma operates through Histogen Inc..